This compound is an Fmoc-protected polyethylene glycol (PEG) linker used in solid-phase peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group, an ether-containing PEG spacer, and a terminal carboxylic acid for conjugation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 166108-71-0
5,8,11-Trioxa-2-azatridecanedioic acid 1-(9H-fluoren-9-ylmethyl) ester
pharmaceutical intermediate
23-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3,6,9,12,15,18,21-heptaoxatricosanoic acid
research compound
5-(9-Fluorenylmethyloxycarbonylamino)-3-oxapentanoic acid
research compound
Fmoc-AEEA-AEEA
pharmaceutical intermediate
3-aminopyrazole-4-carbonitrile
pharmaceutical intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
pharmaceutical intermediate
(R)-1-(4-Fluorophenyl)-1-propanol
pharmaceutical intermediate
(triphenylphosphoranylidene)acetonitrile
pharmaceutical intermediate
2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid
XQPYRJIMPDBGRW-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCC(=O)O